<DOC>
	<DOCNO>NCT02704416</DOCNO>
	<brief_summary>This trial aim develop evidence base curative treatment optimal net benefit patient Brugada syndrome .</brief_summary>
	<brief_title>Ablation Brugada Syndrome Prevention VF</brief_title>
	<detailed_description>This trial aim develop evidence base curative treatment optimal net benefit patient Brugada syndrome . Since recent non-randomized pilot study scarce case report document potential clinical benefit epicardial ablation fragment electrograms region right ventricular outflow tract , patient trial randomize continue implanted cardioverter defibrillator therapy ( control arm ) ablation area fragment electrograms right ventricular outflow tract plus continued implanted cardioverter defibrillator therapy ( intervention arm ) . A projected 92 patient group study .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Brugada Syndrome</mesh_term>
	<criteria>The diagnosis Brugada syndrome base 2013 HRS/EHRA/APHRS Consensus document criteria The patient receive least 1 appropriate ICD shock The patient legally competent , willing able undergo study sign inform consent The patient willing able adhere followup visit protocol A patient meet inclusion criterion A patient previous epicardial ablation A patient pregnant ( would exclude ablation procedure ) A patient comorbid condition posse undue risk general anesthesia epicardial ablation A patient history radiation therapy thorax</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Ventricular arrhythmia</keyword>
	<keyword>aborted cardiac arrest</keyword>
	<keyword>cardiac death</keyword>
</DOC>